iNova Pharmaceuticals is part of the Valeant Pharmaceuticals International group of companies.
Present in the region: South East Asia, Australia, New Zealand, South Africa and India. Valeant’s key local operating units are; iNova Pharmaceuticals, Bausch + Lomb and Solta Medical. These operating units have a diversified local Health-care footprint spanning Over-the-Counter (OTC) consumer products, pharmaceutical prescription products, surgical and medical devices.
iNova Pharmaceuticals was originally borne from Riker Laboratories and 3M Pharmaceuticals Asia-Pacific. Many products originally developed and manufactured by these companies are an important part of iNova’s product range today.
About Valeant Pharmaceuticals International, inc:
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.